Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Enting

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
BMC Urology|August 18, 2021
The incidence and prevalence of upper tract urothelial carcinoma: a systematic reviewAhmed Soualhi, Elke Rammant, Gincy George, et al.
BJU International|March 8, 2020
Overall survival, disease-specific survival and local recurrence outcomes in patients with muscle-invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic reviewLiam Mannion, Cecilia Bosco, Rajesh Nair, et al.
Cancers|October 27, 2022
Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping ReviewJasmine Handford, Miaoqi Chen, Ridesh Rai, et al.
Cancer Chemotherapy and Pharmacology|November 23, 2016
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumorsJames Spicer, Sheeba Irshad, Joo Ern Ang, et al.
British Journal of Cancer|January 8, 2024
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspectiveRobert J Jones, Simon J Crabb, Mark Linch, et al.
BMJ Open|October 9, 2021
Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping reviewMiaoqi Chen, Ridesh Raj, Louis Fox, et al.
Cancers|July 24, 2021
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre ExperienceAlfred Chung Pui So, Harriet McGrath, Jonathan Ting, et al.
Scandinavian Journal of Urology|November 15, 2021
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancerBeth Russell, Fredrik Liedberg, Oskar Hagberg, et al.
BJUI Compass|November 14, 2024
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experimentLiam Mannion, Verity Watson, Vinod Mullassery, et al.
BMC Urology|April 30, 2022
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19Alfred Chung Pui So, Christina Karampera, Muhammad Khan, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
BMC Urology|August 18, 2021
The incidence and prevalence of upper tract urothelial carcinoma: a systematic reviewAhmed Soualhi, Elke Rammant, Gincy George, et al.
BJU International|March 8, 2020
Overall survival, disease-specific survival and local recurrence outcomes in patients with muscle-invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic reviewLiam Mannion, Cecilia Bosco, Rajesh Nair, et al.
Cancers|October 27, 2022
Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping ReviewJasmine Handford, Miaoqi Chen, Ridesh Rai, et al.
Cancer Chemotherapy and Pharmacology|November 23, 2016
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumorsJames Spicer, Sheeba Irshad, Joo Ern Ang, et al.
British Journal of Cancer|January 8, 2024
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspectiveRobert J Jones, Simon J Crabb, Mark Linch, et al.
BMJ Open|October 9, 2021
Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping reviewMiaoqi Chen, Ridesh Raj, Louis Fox, et al.
Cancers|July 24, 2021
COVID-19 Vaccine Safety in Cancer Patients: A Single Centre ExperienceAlfred Chung Pui So, Harriet McGrath, Jonathan Ting, et al.
Scandinavian Journal of Urology|November 15, 2021
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancerBeth Russell, Fredrik Liedberg, Oskar Hagberg, et al.
BJUI Compass|November 14, 2024
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experimentLiam Mannion, Verity Watson, Vinod Mullassery, et al.
BMC Urology|April 30, 2022
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19Alfred Chung Pui So, Christina Karampera, Muhammad Khan, et al.
Pageof 5